Plato Investment Management LTD Bristol Myers Squibb CO Transaction History
Plato Investment Management LTD
- $1.48 Trillion
- Q3 2025
A detailed history of Plato Investment Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plato Investment Management LTD holds 93,470 shares of BMY stock, worth $4.38 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
93,470
Previous 82,194
13.72%
Holding current value
$4.38 Million
Previous $3.79 Billion
10.36%
% of portfolio
0.28%
Previous 0.28%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,709Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...